đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
A study to evaluate the safety, tolerability, and immunogenicity of a recom...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT00489099
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
This study was conducted in healthy infants and will provide new immunogeni...
Status
Completed
Location
Multiple Locations
Start Date
2006-10-06
Trial ID
NCT00414050
The purpose of this trial is to determine if there is an improvement in the...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00440531
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0159)
Start Date
2019-06-19
Trial ID
NCT03893448
Treatments Being Tested
This is a study to evaluate immunogenicity, safety, and tolerability of 2XP...
Status
Completed
Location
Multiple Locations
Start Date
2011-11-29
Trial ID
NCT01463683
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and immun...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT00551915
Treatments Being Tested
The goal of this study is to evaluate the safety, tolerability, and immunog...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0015)
Start Date
2018-10-18
Trial ID
NCT03620162
Treatments Being Tested
To assess the safety and immunogenicity of a booster dose of hepatitis B va...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00393523
Treatments Being Tested
Hepatitis B Vaccine \[Recombinant\] is a well-established vaccine which has...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00322361
Treatments Being Tested